Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Nang Kuang Pharmaceutical Co's average Dividends Per Share Growth Rate was -20.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -3.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Nang Kuang Pharmaceutical Co was -3.90% per year. The lowest was -3.90% per year. And the median was -3.90% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Nang Kuang Pharmaceutical Co (TPE:1752) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Nang Kuang Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Nang Kuang Pharmaceutical Co was 0.86. The lowest was 0.51. And the median was 0.75.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Nang Kuang Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 1.600000
2026-07-02
2026-07-03
2026-07-29
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Nang Kuang Pharmaceutical Co's Dividend Yield (%) for Today is calculated as
Current Share Price is NT$31.55.
Nang Kuang Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$1.6.
During the past 13 years, the highest Dividend Yield of Nang Kuang Pharmaceutical Co was 5.83%. The lowest was 2.23%. And the median was 4.49%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nang Kuang Pharmaceutical Co Dividends per Share Related Terms
Nang Kuang Pharmaceutical Co Dividends per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nang Kuang Pharmaceutical Co Dividends per Share Chart
TPE:1752 vs ISRG, BDX, MDLN: Dividends per Share Comparison
For the Medical Instruments & Supplies subindustry, Nang Kuang Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nang Kuang Pharmaceutical Co Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nang Kuang Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Nang Kuang Pharmaceutical Co's Dividend Yield % falls into.
Nang Kuang Pharmaceutical Co (TPE:1752) has a Dividends per Share of NT$1.60 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Nang Kuang Pharmaceutical Co and its competitors.
Is Nang Kuang Pharmaceutical Co's Dividends per Share too high?
Nang Kuang Pharmaceutical Co's current Dividends per Share is NT$1.60. Overall, Nang Kuang Pharmaceutical Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nang Kuang Pharmaceutical Co's Dividends per Share compare to ISRG and BDX?
Nang Kuang Pharmaceutical Co's Dividends per Share of NT$1.60 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Medical Devices & Instruments company?
A good Dividends per Share depends on the Medical Devices & Instruments industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Nang Kuang Pharmaceutical Co and its competitors. Nang Kuang Pharmaceutical Co's current Dividends per Share is NT$1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nang Kuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co (TPE:1752) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$46.65, compared to a current price of NT$31.55 — trading 32.4% below its estimated fair value. The current Dividends per Share is NT$1.60. Nang Kuang Pharmaceutical Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Nang Kuang Pharmaceutical Co (TPE:1752), the current Dividends per Share is NT$1.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nang Kuang Pharmaceutical Co (TPE:1752) Overvalued in 2026?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$31.55 is trading 32.4% below its estimated GF Value™ of NT$46.65.
GuruFocus considers Nang Kuang Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for TPE:1752:
Dividends per Share: NT$1.60
GF Value™: NT$46.65 vs. price of NT$31.55 (32.4% below fair value)
No single metric tells the full story. See the TPE:1752 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nang Kuang Pharmaceutical Co Ltd is a Taiwan-based company, its subsidiaries are engaged in the manufacture, processing, and trading, and import and export of pharmaceuticals and medical devices. Its products are Cardiovascular system medications, Gastrointestinal medications, Nervous system drugs, Nutrition and Metabolism, Hospital infusion solution, blood products, Anticancer immunomodulators, Musculoskeletal system, and Others. Geographically, the company operates in Taiwan, China, Japan, the USA, and Other countries.
88GF Score
Get the complete analysis for TPE:1752
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1752 has been successfully added to your 
